Business Wire

NTT DATA Unveils Smart AI Agent™ Ecosystem, Revolutionizing Industry Solutions with Intelligent Automation and Strategic Alliances

15.5.2025 14:00:00 CEST | Business Wire | Press release

Share

Smart AI Agent™ offers industry-specific solutions with assured outcomes Agentic ecosystem and services portfolio support clients end-to-end, from advisory to agent management Patented plug-in solution transforms RPA bots into intelligent agents NTT DATA to establish an OpenAI Center of Excellence to accelerate the development and deployment of Smart AI Agents.

NTT DATA, a global leader in digital business and technology services, today announced a comprehensive enterprise-grade Smart AI Agent™ Ecosystem with industry-specific solutions to help clients transform their business. The company also announced a patented plug-in solution that turns legacy bots into autonomous intelligent agents, and an expanded key alliance network for providing best-fit solutions.

"The rapid evolution of AI presents both immense opportunities and challenges for businesses," said Yutaka Sasaki, President and Chief Executive Officer, NTT DATA Group. "At NTT DATA, we have developed the comprehensive capabilities needed to guide our clients through these transformative times and empower them to shape their future with the power of AI."

Assured outcome solutions with embedded Smart AI Agent

NTT DATA has deployed hundreds of Smart AI Agent instances in support of sophisticated processes and decision-making at clients. The company’s roadmap encompasses a continuous stream of new agents to support more complex use cases from a range of industries as well as shared functions. For example:

  • Healthcare: Current agents are autonomously classifying, prioritizing and summarizing insurance appeals and making decisions about medical necessity among other responsibilities. The near-term roadmap includes agents that specialize in early interventions, medication compliance, payer validation, and preventing fraud, waste and abuse.
  • Automotive manufacturing: Agents already are analyzing regulatory warning letters and citations. The company is now developing agents that specialize in root-cause analysis of defects; initiate corrective actions, recalls or fixes; and launch compliance reviews as needed.
  • Finance: Agentic AI solutions are assisting banks, partners and consumers in the continuous pursuit of client and engagement validation requirements, including Know Your Customer and other fraud detection and anti-crime capabilities, minimizing transaction and payment vulnerability.
  • Supply chain and logistics: Agents are helping clients select and securely do business with AI startup partners, while also building AI agent prototypes to help businesses deploy and integrate pilots with purchasing workflows and processes, and monitoring adoption, performance and return on investment. Next up are domain-specific steps including agents that intelligently manage procurement services.
  • Marketing: In one of many examples, a multi-agent system integrates with a hyperscaler platform to autonomously analyze and categorize user profiles and build psychographic profiles for hyper-personalized ad recommendations. This system continuously learns and adapts, delivering boosted sales and revenue to clients in many industries.

Based on the company’s comprehensive approach to agentic AI, NTT DATA can offer assured outcomes that help clients heighten performance, improve security and cyber resilience, and ignite innovation for profitable growth and superior stakeholder experiences.

“Agentic AI is the next transformative wave that will impact every sector, far more than what we have seen with Generative AI so far,” said Abhijit Dubey, CEO of NTT DATA, Inc. “It’s not just about boosting creativity or productivity. It’s about unlocking new capabilities that can take initiative, make decisions and collaborate with humans in entirely new ways. With our deep expertise in responsible innovation, trailblazing alliances, and visionary clients, we’re excited to lead this future — building the foundation for a reimagined human-machine hybrid workplace and a bold new business landscape.”

Comprehensive Smart AI Agent Ecosystem guides clients through AI adoption

NTT DATA’s Smart AI Agent Ecosystem builds on previous developments to scale the breadth and agility of composable agentic AI solutioning. Key components include:

  • Managed agentic services that help clients build, adopt, manage and scale transformative solutions.
  • Solutions with embedded Smart AI Agents that offer assured outcomes for clients, including solutions for specific industries and horizontal functions.
  • Additional Smart AI Agents targeting industry and horizontal needs.
  • Smart AI Agent platform that incorporates integrated tools, utilities, accelerators and best practices; and access to a marketplace with additional agents, large language models (LLMs) and small language models (SLMs).
  • AI-ready infrastructure backed by services that leverage public cloud, private cloud, network and cybersecurity.
  • Alliances with world-leading technology providers and world-class startups.
  • Responsible by design including security, governance and compliance.

The expanded ecosystem empowers clients to envision new ways of operating with smarter automation, resolve global skills shortages and maximize return on investments. Clients also benefit from the assurance of working with a trusted, full-service provider with global scale, scope and expertise.

The Smart AI Agent Ecosystem is complemented by an array of proven NTT DATA services including structured readiness and risk assessments, managed services tailored to hyperscaler AI offerings, and multi-agent management services in hybrid vendor environments. Every aspect of the ecosystem is grounded in the company’s commitment to responsible AI – ensuring it is trustworthy, ethical and secure by design.

“We’ve been leveraging NTT DATA’s end-to-end Agentic AI Services for Hyperscaler AI Technologies to explore both pro-code and low-code agentic AI experiences,” said Pankaj Shah, VP, Chief Information and Digital Officer, Hyster-Yale Materials Handling, Inc. “With their step-by-step advisory approach and outcome-focused strategy, we’re now exploring powerful multi-agent models and identifying new use cases to align with our business objectives and to reimagine how we operate.”

Industry-leading alliances and partnerships offer deep choice

NTT DATA recently announced a strategic collaboration agreement with OpenAI to drive innovation in generative AI. As part of this agreement, NTT DATA will establish an OpenAI CoE (Center of Excellence) to accelerate the development and deployment of new generative AI services powered by the OpenAI APIs. These services will be tailored to specific industries and business functions, and will be introduced globally to deliver enhanced value to clients.

In addition to formal collaborations with world-leading technology providers, NTT DATA also has established alliances with world-class innovative startups including, for example:

  • Rafay Systems: Rafay’s platform supports NTT DATA’s delivery of a scalable, secure and developer-friendly Platform-as-a-Service experience on top of AI infrastructure (GPU PaaS), enabling enterprises to streamline GenAI adoption, reduce operational complexity and accelerate the deployment of production-grade AI workloads.
  • Kore.ai: The enterprise-grade Kore.ai Agent Platform integrates LLMs to enhance NTT DATA’s Digital Workplace Services. This GenAI-powered automation enables NTT DATA to enhance Service Desk operations, reduce costs and deliver personalized context-aware support to various clients.

Agentic AI services portfolio meets clients where they are with end-to-end ecosystem

The company’s previously announced Agentic AI Services for Hyperscaler AI Technologies offers a comprehensive suite of cloud-managed services to help organizations harness the full potential of agentic AI by leveraging hyperscaler AI technologies.

NTT DATA is rapidly scaling their Agentic AI Services for Hyperscaler AI Technologies to deliver greater value as organizations increasingly mature on agentic AI and adopt multi-AI agent models. For example, leveraging Azure AI Agent Service on Azure AI Foundry, NTT DATA can build, manage and orchestrate multi-agent workflows across multiple platforms. This approach simplifies complex multi-agent deployments.

Additionally, NTT DATA is helping clients work across the agentic AI spectrum by making its tooling available across clients’ cloud platforms. This means that any agent NTT DATA builds can easily be transferred to a clients’ cloud environment across Microsoft Azure, AWS and Google Cloud Platform.

Patented solution transforms bots into autonomous intelligent agents

NTT DATA also announced a patented solution that transforms legacy bots into intelligent agent assets. This plug-in capability is especially important to companies that want to adopt AI but are constrained by technological debt. Millions of Robotic Process Automation (RPA) bots have been deployed by businesses worldwide for rules-based automation. Similar to a plug-in module that turns a basic television into a smart TV, NTT DATA’s new solution can transform bots into intelligent agents that operate autonomously while complying with governance and policies for security and privacy.

“AI is causing a massive shift similar to the early days of the internet — reshaping how we work, solve problems and create value,” Dubey said. “We’re not just watching this future unfold — we’re driving it. At NTT DATA, we’re delivering clients real, measurable impact from AI solutions already, and this patented, transformative plug-in is just one more proof point of what’s possible when innovation meets execution.”

Visit our website for more information about NTT DATA’s Smart AI Agent Ecosystem. To learn about additional case studies, please read “A Force for Good: How AI and GenAI are reshaping our world.”

About NTT DATA

NTT DATA is a $30+ billion trusted global innovator of business and technology services. We serve 75% of the Fortune Global 100 and are committed to helping clients innovate, optimize and transform for long-term success. As a Global Top Employer, we have experts in more than 50 countries and a robust partner ecosystem of established and startup companies. Our services include business and technology consulting, data and artificial intelligence, industry solutions, as well as the development, implementation and management of applications, infrastructure and connectivity. We are also one of the leading providers of digital and AI infrastructure in the world. NTT DATA is part of NTT Group, which invests over $3.6 billion each year in R&D to help organizations and society move confidently and sustainably into the digital future. Visit us at nttdata.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250515945815/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye